Lactobacillus Acidophilus for Cholesterol Management

Research suggests that Lactobacillus acidophilus, particularly when combined with other probiotic strains, may contribute to improvements in cholesterol-related markers. The available evidence on this specific application comes from a single animal study published in 2024, which found that a multi-strain probiotic yogurt containing L. acidophilus reduced total cholesterol, LDL, and triglycerides while supporting HDL levels in rats fed a high-fat diet. Studies indicate a generally supportive direction for this use, though the evidence base is limited by the lack of human clinical trials, and it remains unclear how well these findings would translate to people. The current research should be considered preliminary, and the cholesterol-related benefits observed may reflect the combined effect of multiple bacterial strains rather than L. acidophilus acting alone.